Ten-Year Trends in Sales of Alzheimer Disease Drugs in France Compared With Sales in Germany, Spain, and the UK

JAMA Health Forum. 2022 Aug 5;3(8):e222253. doi: 10.1001/jamahealthforum.2022.2253. eCollection 2022 Aug.

Authors

Céline Ben Hassen¹, Rameen Tahir¹, Archana Singh-Manoux¹, Dejan Milic², Claire Paquet³, Séverine Sabia¹, Julien Dumurgier^{1

3}

Affiliations

¹ Université Paris Cité, Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
² IQVIA, Paris, France.
³ Université Paris Cité, Cognitive Neurology Center, Lariboisiere-Fernand Widal Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Abstract

This cross-sectional study analyzes 10-year trends in sales of Alzheimer disease drugs in France compared with trends in the UK, Spain, and Germany.

Copyright 2022 Ben Hassen C et al. JAMA Health Forum.

MeSH terms

Alzheimer Disease* / drug therapy
Cross-Sectional Studies
Germany / epidemiology
Humans
Spain / epidemiology
United Kingdom

Grants and funding

MR/S011676/1/MRC_/Medical Research Council/United Kingdom